Lifeboat Foundation

Q&A

Legaltech News sat down with the leaders of AI detection company Copyleaks to discuss the findings of their study that found that almost 60% of OpenAI’s GPT-3.5 outputs included some form of plagiarism, and the effectiveness of uncovering AI use.

Multiresolution computational simulations generate all-atom models of a complete packaged virus particle.

How LLM #ai is transforming the science of cells and propelling new discoveries by @carlzimmer v/EricTopol.

Given troves of data about genes and cells, A.I.

Given troves of data about genes and cells, A.I. models have made some surprising discoveries. What could they teach us someday?

Continue reading “A.I. Is Learning What It Means to Be Alive” »

Calum and David recently attended the BGI24 event in Panama City, that is, the Beneficial General Intelligence summit and unconference. One of the speakers we particularly enjoyed listening to was Daniel Faggella, the Founder and Head of Research of Emerj.

Something that featured in his talk was a 3 by 3 matrix, which he calls the Intelligence Trajectory Political Matrix, or ITPM for short. As we’ll be discussing in this episode, one of the dimensions of this matrix is the kind of end goal future that people desire, as intelligent systems become ever more powerful. And the other dimension is the kind of methods people want to use to bring about that desired future.

Continue reading “The Political Singularity and a Worthy Successor, with Daniel Faggella” »

How deep is the lunar regolith and megaregolith, the latter of which consists of the cracked lunar crust layers resulting from billions of years of impact craters? This is what the Synthetic Pulse Artemis Radar for Crustal Imaging (SPARCI, pronounced “sparky”) instrument hopes to address as the Southwest Research Institute (SwRI) was recently awarded a 3-year, $2,041,000 grant from NASA’s Development and Advancement of Lunar Instrumentation (DALI) program as part of advancing lunar exploration technologies.

Image of the Synthetic Pulse Artemis Radar for Crustal Imaging (SPARCI, pronounced “sparky”). (Credit: Southwest Research Institute/Bryan Pyke)

“Learning more about the lunar megaregolith will help us gain a wider understanding of the Moon’s formation and that of similar bodies with thin, sparse atmospheres,” said Dr. David Stillman, who is a geophysicist at SwRI and SPARCI’s principal investigator. “If we are able to pinpoint exactly where this layer begins, we can use that to create more accurate formation and evolution models.”

Apple announces MM1

Methods, Analysis & Insights from Multimodal LLM Pre-training.

In this work, we discuss building performant Multimodal Large Language Models (MLLMs).

Continue reading “MM1: Methods, Analysis & Insights from Multimodal LLM Pre-training” »

Long-wavelength infrared (LWIR) imaging holds critical significance across many applications, from consumer electronics to defense and national security. It finds applications in night vision, remote sensing, and long-range imaging. However, the conventional refractive lenses employed in these imaging systems are bulky and heavy, which is undesirable for almost all applications. Compounding this issue is the fact that many LWIR refractive lenses are crafted from expensive and limited-supply materials, such as germanium.

New tech enables this old idea to really shine. [pun intended.] It’s not perfect, but major steps achieved.

Get TypeAI PREMIUM now! Start your FREE trial by clicking the link here: https://bit.ly/Mar24AnastasiInTech The paper: https://www.nature.com/articles/s41586…(alternative link): https://arxiv.org/abs/2306.14415 LinkedIn ➜ / anastasiintech Support me at Patreon ➜ / anastasiintech Sign up for my Deep In Tech Newsletter for free! ➜ https://anastasiintech.substack.com Timestamps: 00:00 — Intro 03:16 — Lithium Niobate 05:56 — How does this chip work? 08:23 — Critics.

The blockbuster weight loss drug semaglutide can cut the progression of diabetic kidney disease, according to its manufacturer Novo Nordisk, adding to growing evidence that the medication has beneficial effects beyond treating Type 2 Diabetes and obesity.

Semaglutide — which is marketed under the name Ozempic for diabetes treatment and Wegovy for weight loss — managed to also reduce death from kidney disease and cardiovascular issues by 24 percent versus a placebo.

The results came from a Novo Nordisk clinical trial that had 3,533 participants with both diabetes and chronic kidney disease. High blood sugar from diabetes can damage kidneys and ultimately lead to chronic kidney disease, in which the organ has trouble filtering toxins from the blood.